Canopy Growth Corporation · TSX:WEED

Canopy Growth — Investor Presentation (February 2018)

18 slides from Canopy Growth's investor presentation, February 2018

  1. Slide 1: Driving the Global Cannabis Industry

    DRIVING THE GLOBAL CANNABIS INDUSTRY February 2018

  2. Slide 2: Forward-Looking Statement

    FORWARD-LOOKING STATEMENT This presentation contains “forward-looking information” within the meaning of applicable Canadian securities laws and “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 (collectively, “Forward-Looking State

  3. Slide 3: Company Snapshot

    COMPANY SNAPSHOT Operations in 7 countries Canopy Growth is a world-leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and 7 world-class facilities, indoor capsule forms and greenhouse production, combined 665,000 sq. ft. Share Price Performan

  4. Slide 4: Strategic Relationship with Constellation Brands

    STRATEGIC RELATIONSHIP Sales US $7.2B! $245M investment: expansion Cannabis-based beverage plans well funded development collaboration 4

  5. Slide 5: Cannabis – A New Global Market

    CANNABIS – A NEW GLOBAL MARKET The legalization of Cannabis is spreading around the world Legalized In the process of legalizing/exploring legalization (medical) 5

  6. Slide 6: Cannabis - A New Global Market

    CANNABIS - A NEW GLOBAL MARKET 1 2024, Source: Health Canada 2 Source: Deloitte, “Recreational Marijuana Insights and Opportunities”. 3 Source: Eight Capital, “The Value Case for Investing in the Cannabis Sector”. 6

  7. Slide 7: Core Products

    CORE PRODUCTS STRAIN CLASSIFICATION 7

  8. Slide 8: Brand Strategy

    BRAND STRATEGY The diverse brands “under the Canopy” allow us to effectively deploy brands that are targeted towards specific customer demographics, use occasions and product form factors MEDICAL PREMIUM AFFILIATE VALUE ADDED CUSTOMER ACCESS 8

  9. Slide 9: Canadian Regulated Recreational Market - July 2018

    CANADIAN REGULATED RECREATIONAL MARKET - JULY 2018 $7 - 10B* $? $9B $6B $5B + Estimate, http://www.pbo-dpb.gc.ca/en /b log /ne w s/Lega li zed _Ca nna bi s http://www.statcan.gc.ca/daily- qu oti die n/1 6051 0/ dq16 0510 b-eng.h tm * Estimate, Avery Shenfeld, Chief Economist, CIBC World Markets, htt

  10. Slide 10: Provinces Are Driving Rec. Market Supply

    PROVINCES ARE DRIVING REC. MARKET SUPPLY Supply Certainty • 4 or 5 Primary Suppliers/Province • Multi-Year Agreements Signed Q1 Q2 Q1 CY18DAY 0 DAY 90+ SUPPLY SUPPLY JULY 2018 Deliveries For Inventory Q2 CY18 Q1 CY18 Deliveries For Capacity In-Production Q3 CY18 Q1 CY18 Significant Production Capaci

  11. Slide 11: Proud Business Partner

    PROUD BUSINESS PARTNER $74M Inventory1 • 3.5M+ sq. ft. Production Expected By March 20182 • Investments in 7 Provinces Newfoundland & Labrador Supply, Development & Retail 2 years • 8,000 kg/yr •4 stores New Brunswick Historic Supply MOU 2 years • 4,000 kg/yr • Education Prince Edward Island Multi-f

  12. Slide 12: Leveraging the Canopy Platform & Supply Channel

    LEVERAGING THE CANOPY PLATFORM & SUPPLY CHANNEL 12

  13. Slide 13: Canopy Health - Advancing Medical Cannabis

    CANOPY HEALTH - ADVANCING MEDICAL CANNABIS Developing safe, effective, natural medicines derived from cannabis Global IP Protection 27 Patent Applications filed with USPTO 13

  14. Slide 14: Aggressive Global Expansion

    AGGRESSIVE GLOBAL EXPANSION 14

  15. Slide 15: Management Team

    MANAGEMENT TEAM Bruce Linton Mark Zekulin Tim Saunders Chairman & CEO President EVP & Chief Financial Officer 15

  16. Slide 16: Management Team

    MANAGEMENT TEAM Olivier Dufourmantelle Amanda Daley Rade Kovacevic Dave Bigioni SVP, Facility Expansion and VP, Medical SVP & Managing Director, Canada Chief Marketing Officer Process Improvement 16

  17. Slide 17: Performance Highlights

    PERFORMANCE HIGHLIGHTS Revenue ($M) Sales (Kg & Kg equiv.) Patients 17.6 70,000 15.9 2,020 63,500 14.7 1,830 55,600 59,000 1,740 9.5 1,169 1,245 8.5 29,200 24,400 Q217 Q317 Q417 Q118 Q218 Q217 Q317 Q417 Q118 Q218 Q217 Q317 Q417 Q118 Q218 Recent Avg. Sales Price per Gram Weighted Avg. Cost per Gram1

  18. Slide 18: invest@canopygrowth.com

    invest@canopygrowth.com 18

Canopy Growth — Investor Presentation (February 2018) on 6ix